Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter

Autor: Qingrui Sun, Jing Zhang, Xiaofan Wei, Feng Li, Lihua Ding, Yan Tang, Jun Zhan, Xiang Wang, Hongquan Zhang, Yang Yuan, Qinong Ye
Rok vydání: 2018
Předmět:
0301 basic medicine
animal structures
Lung Neoplasms
Time Factors
Active Transport
Cell Nucleus

Mice
Nude

Muscle Proteins
Uterine Cervical Neoplasms
Adenocarcinoma of Lung
macromolecular substances
Biology
Binding
Competitive

Article
Focal adhesion
03 medical and health sciences
Cell Movement
Animals
Humans
Neoplasm Invasiveness
Phosphorylation
Transcription factor
Research Articles
Cell Proliferation
Mice
Inbred BALB C

Cell growth
Tumor Suppressor Proteins
Intracellular Signaling Peptides and Proteins
Membrane Proteins
Cell Biology
LIM Domain Proteins
Actin cytoskeleton
Neoplasm Proteins
Tumor Burden
Cell biology
Repressor Proteins
src-Family Kinases
030104 developmental biology
Female
Signal transduction
Tyrosine kinase
HeLa Cells
Protein Binding
Signal Transduction
Proto-oncogene tyrosine-protein kinase Src
Zdroj: The Journal of Cell Biology
ISSN: 1540-8140
0021-9525
DOI: 10.1083/jcb.201708064
Popis: Wang et al. unveil a new mechanism by which Src may function as an oncogene. Phosphorylation of FHL1 by Src triggers the translocation of FHL1 to the nucleus, where it regulates the activity of the transcription factor BCLAF1 to promote tumor cell growth and loses the ability to regulate cell adhesion and suppress growth.
FHL1 has been recognized for a long time as a tumor suppressor protein that associates with both the actin cytoskeleton and the transcriptional machinery. We present in this study a paradigm that phosphorylated FHL1 functions as an oncogenic protein by promoting tumor cell proliferation. The cytosolic tyrosine kinase Src interacts with and phosphorylates FHL1 at Y149 and Y272, which switches FHL1 from a tumor suppressor to a cell growth accelerator. Phosphorylated FHL1 translocates into the nucleus, where it binds to the transcription factor BCLAF1 and promotes tumor cell growth. Importantly, the phosphorylation of FHL1 is increased in tissues from lung adenocarcinoma patients despite the down-regulation of total FHL1 expression. Kindlin-2 was found to interact with FHL1 and recruit FHL1 to focal adhesions. Kindlin-2 competes with Src for binding to FHL1 and suppresses Src-mediated FHL1 phosphorylation. Collectively, we demonstrate that FHL1 can either suppress or promote tumor cell growth depending on the status of the sites for phosphorylation by Src.
Databáze: OpenAIRE